Neuropathy treatment works best when it targets both the underlying cause and the symptoms at the same time. No single pill reverses nerve damage for everyone, but a combination of the right medications, metabolic control, exercise, and sometimes newer technologies like spinal cord stimulation can meaningfully reduce pain and, in some cases, help nerves regrow. The challenge is that neuropathy has dozens of causes, and what works for diabetic nerve damage may do little for chemotherapy-induced tingling. Sorting through which treatments have real evidence behind them, and which are mostly hype, is where most people get stuck.
Medications With the Strongest Track Record
For neuropathic pain specifically, a handful of drug classes have been tested extensively enough to be considered first-line options. Pregabalin and gabapentin, which belong to the same drug family, work by calming overactive nerve signaling. Clinical trials across diabetic neuropathy, post-shingles nerve pain, and fibromyalgia have consistently shown pregabalin reduces pain scores, and a systematic review with meta-analysis confirmed that both gabapentinoids significantly reduce pain compared with placebo.1PubMed Central. The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials Pregabalin tends to outperform gabapentin on several measures, though it also carries more side effects like drowsiness and dizziness.2PubMed. Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature
The other major class is antidepressants, not because neuropathy is “in your head,” but because certain antidepressants act on the same pain-modulating pathways in the spinal cord and brain. Duloxetine and amitriptyline are the two most studied. In a head-to-head trial of painful diabetic neuropathy, both performed similarly well: roughly half of patients on either drug achieved good pain relief.3PubMed Central. A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial Duloxetine tends to be prescribed more often today because it has fewer side effects than amitriptyline, especially in older adults, who are more vulnerable to the dry mouth, constipation, and heart rhythm changes that older-style antidepressants can cause. Your doctor will typically start with one of these classes and adjust based on how you respond.
Topical Options for Localized Pain
When pain is concentrated in a specific area, like the feet or hands, topical treatments let you deliver relief directly to the problem spot without the systemic side effects of oral medications. Two topical agents have the best evidence: lidocaine patches and high-dose capsaicin patches.
Lidocaine patches (5%) work by quieting the sodium channels on local nerve fibers, essentially muting their ability to fire pain signals. Long-term use may actually reduce the density of overactive nerve fibers in the skin, which is part of why the benefit can build over weeks.4Journal of Pain and Symptom Management. Topical Treatment of Peripheral Neuropathic Pain: Applying the Evidence Lidocaine patches are generally considered a first-line local treatment when oral medications alone aren’t enough.5PubMed Central. The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain
Capsaicin, the compound that makes chili peppers hot, follows a counterintuitive logic: it initially fires up pain nerve endings, then causes them to go quiet for weeks or months. The key is concentration. Over-the-counter capsaicin creams at low doses have not shown strong results, but the prescription-strength 8% capsaicin patch has some of the best data available for post-shingles nerve pain and other neuropathic conditions.6PubMed Central. Capsaicinoids in the treatment of neuropathic pain: a review It is applied in a clinic setting because that initial burn can be intense, but the payoff is pain relief that can last up to three months from a single application.
Why Controlling Metabolism Matters More Than Any Single Drug
If your neuropathy stems from diabetes or prediabetes, no medication can substitute for getting your blood sugar, weight, and cholesterol under control. The landmark DCCT/EDIC trials demonstrated that intensive blood sugar management is essential to preventing or slowing nerve damage in type 1 diabetes.7PubMed Central. Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials The picture for type 2 diabetes is more complicated. Blood sugar control alone seems less protective, and research using advanced nerve imaging has shown that the dominant type of nerve damage in type 2 diabetes is more closely linked to abnormal lipid metabolism than to glucose levels alone.8PubMed. Diabetic neuropathy differs between type 1 and type 2 diabetes: Insights from magnetic resonance neurography
This means that for people with type 2 diabetes, addressing cholesterol, triglycerides, and body weight may matter as much as, or more than, simply driving down blood sugar numbers. Animal studies support this: when mice fed a high-fat diet were switched back to normal food, their neuropathy completely normalized, along with improvements in weight, insulin sensitivity, and cholesterol.9Disease Models & Mechanisms. Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome In a human study of severely obese individuals, dietary weight loss over two years stabilized neuropathy and improved symptoms, though the density of nerve fibers in the skin did not significantly change.10PubMed Central. Dietary weight loss in the severely obese stabilizes neuropathy and improves symptomatology The practical takeaway: losing weight and improving your metabolic profile can stop neuropathy from getting worse, even if it doesn’t regenerate nerves overnight.
Exercise as a Nerve-Repair Tool
Exercise is one of the few interventions shown to do more than manage symptoms. Aerobic exercise hits multiple pathways that contribute to nerve damage, including inflammation, blood sugar regulation, and blood flow to peripheral nerves, all at once. In both animal and human studies, regular aerobic exercise has improved neuropathy symptoms and actually promoted the regrowth of small nerve fibers in the skin.11PubMed. Exercise as Therapy for Diabetic and Prediabetic Neuropathy That last point is worth emphasizing: very few treatments can claim to regenerate nerve fibers, but exercise has evidence for it.
The catch is that neuropathy itself makes exercise harder. Numbness in the feet compromises balance, and pain can make walking miserable. Starting with low-impact activities like swimming, cycling, or chair-based exercises lets you build up gradually. Even moderate amounts of walking, done consistently, have shown benefits. If balance is a concern, working with a physical therapist to develop a safe routine is a reasonable investment. Exercise also contributes to the metabolic improvements discussed above, so the effects compound.
Supplements Worth Considering and One to Watch Out For
The supplement aisle is packed with products claiming to help neuropathy, but only a few have clinical trial data behind them. Alpha-lipoic acid is the standout. It is a potent antioxidant that appears to delay or reverse peripheral diabetic neuropathy, and clinical trials have shown that a daily dose of 600 mg improves neuropathic deficits.12PubMed Central. Alpha-lipoic Acid and diabetic neuropathy Multiple pre-clinical and clinical studies support its pain-reducing effects in neuropathy.13PubMed Central. Alpha-Lipoic Acid as an Antioxidant Strategy for Managing Neuropathic Pain It is widely available over the counter and generally well tolerated, though it can lower blood sugar, so people on diabetes medications should coordinate with their doctor.
Vitamin B6, on the other hand, is one of the more important cautionary tales in neuropathy treatment. Many supplement blends marketed for nerve health contain high doses of B6, but the evidence is paradoxical: taking too much B6 can actually cause a sensory neuropathy, primarily affecting sensation. A systematic review found that higher B6 levels, usually from supplementation, may lead to the development of sensory nerve damage. After people stop taking excess B6, they tend to report improvement.14PubMed Central. The Role of Vitamin B6 in Peripheral Neuropathy: A Systematic Review Meanwhile, low B6 levels are seen in some neuropathy patients, but there is no firm evidence that low levels directly cause peripheral neuropathy. So if you are already taking a B-complex supplement for nerve health and your neuropathy is worsening, the supplement itself could be the problem. Check your B6 intake and discuss it with your doctor before adding more.
Spinal Cord Stimulation for Severe Cases
For people with painful diabetic neuropathy who have tried medications and still live in daily agony, spinal cord stimulation has become a serious option. The technology involves surgically implanting small electrodes near the spinal cord, which deliver electrical pulses that interrupt pain signaling before it reaches the brain. The FDA has approved it specifically for painful diabetic neuropathy.
The results from clinical trials are striking. In a randomized trial, about 85% of patients receiving high-frequency spinal cord stimulation alongside standard medical care achieved at least a 50% reduction in pain at six months, compared with just 5% of those on medical care alone. Average pain scores dropped from about 7.6 out of 10 at baseline to 1.7 at six months.15JAMA Neurology. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial Newer high-frequency stimulation at 10 kHz can achieve this pain relief without the tingling sensation that older stimulation devices produced.16PubMed Central. Spinal Cord Stimulation for Painful Diabetic Neuropathy
Beyond pain relief, a large real-world cohort study found that patients with spinal cord stimulators had roughly half the rate of all-cause mortality and substantially lower rates of major cardiac events, hospitalizations, and even below-knee amputations compared with patients managed with medications alone.17The Lancet Regional Health or eClinicalMedicine. Real-world evidence of spinal cord stimulation in painful diabetic neuropathy: a global cohort study These are observational findings, and patients selected for stimulation may differ from those who are not, but the numbers are large enough to take seriously. Spinal cord stimulation is invasive, expensive, and not right for mild cases, but for people who have exhausted other options, the evidence is increasingly compelling.
Chemotherapy-Induced Neuropathy Has Its Own Playbook
If your neuropathy comes from cancer treatment rather than diabetes, the landscape is different. Chemotherapy drugs, particularly taxanes like paclitaxel, damage peripheral nerves directly, and the resulting numbness, tingling, and pain can persist for months or years after treatment ends. Prevention during chemotherapy matters enormously because once the damage is done, reversal is limited.
Compression therapy is the most exciting development in prevention. Wearing tight surgical gloves or specialized compression garments on the hands and feet during chemotherapy infusions appears to reduce blood flow to the extremities, limiting how much of the toxic drug reaches peripheral nerves. A randomized adaptive selection trial in breast cancer patients found that compression therapy was the most effective intervention compared with cryotherapy and placebo for preventing neuropathy.18PubMed Central. Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer Another trial in gynecologic cancer patients showed that compression significantly reduced the rate of moderate-to-severe neuropathy, and the benefits persisted at three and six months after treatment ended, suggesting it prevents irreversible nerve damage rather than just masking symptoms.19Journal of Clinical Oncology. Limb compression therapy and chemotherapy-induced peripheral neuropathy in women with gynecologic cancers: A prospective self-controlled study (NEURO-GLOVE Trial)—Updated long-term analysis Compression gloves were also rated significantly more comfortable and less painful than frozen gloves, a practical consideration when you’re already enduring chemotherapy.20PubMed. Compression therapy with surgical gloves compared to cold therapy with frozen gloves in preventing paclitaxel-induced peripheral neuropathy
For treating chemotherapy-induced neuropathic pain that has already developed, duloxetine is the only medication with solid trial evidence. In a randomized trial, patients taking duloxetine reported an average pain decrease about three times greater than those on placebo, and roughly 59% of duloxetine patients reported some degree of pain reduction.21JAMA. Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy: A Randomized Clinical Trial It’s not a cure, but for a condition with few proven treatments, it’s the strongest card on the table.
Cannabis-Based Medicines and the Reality of the Data
Many people with neuropathy ask about cannabis, and the science is more nuanced than advocates or opponents typically suggest. A Cochrane review, the gold standard for evidence synthesis, found that cannabis-based medicines may increase the number of people achieving at least a 30% pain reduction compared with placebo, but the benefit was modest. For achieving 50% or greater pain relief, you would need to treat about 20 people to see one extra person benefit beyond what placebo provides.22PubMed Central. Cannabis‐based medicines for chronic neuropathic pain in adults The review also concluded that the potential benefits might be outweighed by harms including dizziness, sedation, and cognitive effects.
More recent systematic reviews have been somewhat more optimistic. One meta-analysis found a statistically significant reduction in pain scores of about 0.67 points on a 0-to-10 scale across 14 studies, with improvements in sleep and quality of life as secondary benefits.23PubMed. The Use of Cannabinoids in the Treatment of Peripheral Neuropathy and Neuropathic Pain: A Systematic Review Another found that products containing THC, either alone or combined with CBD, produced significant pain reductions, while CBD alone, CBDV, and the synthetic cannabinoid CT-3 did not.24PubMed Central. Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis The practical takeaway: THC-containing formulations have the best evidence, CBD-only products do not appear effective for neuropathic pain based on current data, and the effect sizes are small enough that cannabis is best considered an add-on rather than a primary treatment.
Nerve Decompression Surgery
In some patients, neuropathy symptoms are worsened or even caused by physical compression of nerves at anatomical bottleneck points, like the carpal tunnel in the wrist or the tarsal tunnel in the ankle. Diabetic nerves are especially vulnerable to entrapment because metabolic damage makes them swell and less tolerant of pressure. When a nerve compression component is present, surgical release of the affected nerve can significantly improve symptoms.
The key is proper patient selection. Signs that suggest entrapment is contributing include a positive Tinel sign (tingling when the nerve is tapped at the compression site), focal pain at the anatomical bottleneck, and changes in two-point discrimination. These signs were found to be prognostic factors for good surgical outcomes, likely because they indicate an earlier, more reversible stage of nerve compression.25PubMed Central. Nerve decompression for diabetic peripheral neuropathy with nerve entrapment: a narrative review This surgery is not appropriate for all neuropathy patients, only those with a demonstrable entrapment component layered on top of their underlying neuropathy.
Alcohol-Related Neuropathy and Stopping the Source
Chronic heavy alcohol use is one of the most common non-diabetic causes of peripheral neuropathy, and the most important treatment is also the most obvious: stop drinking. Alcohol damages nerves through both direct toxicity and the nutritional deficiencies that accompany heavy drinking, particularly B-vitamin depletion. Replenishing B vitamins, especially thiamine (B1), is standard practice during alcohol withdrawal.
An interesting clinical wrinkle, though, is that neuropathy symptoms can sometimes appear or worsen after someone stops drinking, even when B vitamins are being supplemented. Case reports have described acute, asymmetric neuropathy developing for the first time well after cessation of alcohol, in patients who had no neuropathy while they were still drinking and who were already receiving vitamin supplementation.26PubMed Central. Neuropathy after alcohol withdrawal This does not mean quitting alcohol is harmful to nerves, but it does mean that new or worsening symptoms after stopping should be evaluated rather than dismissed as expected withdrawal effects.
How to Know Whether Treatment Is Working
A frustrating aspect of neuropathy treatment is that improvement is often slow and hard to measure. You might feel somewhat less pain, or the area of numbness might shrink slightly, but the changes can be subtle enough that you’re unsure they’re real. This is where diagnostic tools come in.
Skin biopsy has become one of the most useful objective measures. A small punch biopsy of the skin, usually from the lower leg, allows doctors to count the density of small nerve fibers in the epidermis. This technique is more sensitive than nerve conduction studies for detecting small-fiber neuropathy, which is the type responsible for burning, tingling, and pain.27PubMed. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy Repeating a skin biopsy after a period of treatment can show whether nerve fiber density has stabilized, declined, or improved, providing concrete evidence that goes beyond how you feel on a given day.28PubMed Central. Investigation of nerve fibers in the skin by biopsy: technical aspects, indications, and contribution to diagnosis of small-fiber neuropathy If your doctor has not mentioned skin biopsy and your neuropathy is primarily characterized by pain or burning with normal nerve conduction results, it is worth asking about.
Platelet-Rich Plasma and Regenerative Approaches
Regenerative medicine for nerve repair is still in relatively early stages, but platelet-rich plasma (PRP) is generating interest. PRP is prepared from your own blood by concentrating the platelets, which release a cocktail of growth factors when activated. These growth factors promote the proliferation and differentiation of tissue cells, which can accelerate nerve regeneration.29PubMed Central. Evaluation of Platelet-Rich Plasma Therapy for Peripheral Nerve Regeneration: A Critical Review of Literature PRP has been shown to enhance axonal growth, reduce scar formation, stimulate Schwann cell proliferation (Schwann cells are the support cells that insulate and nourish peripheral nerves), and modulate inflammation. Combining PRP with surgical repair and biomaterial scaffolds has shown the best results so far.30PubMed Central. Platelet-rich plasma in peripheral nerve injury repair: a comprehensive review of mechanisms, clinical applications, and therapeutic potential
Most of the evidence for PRP in peripheral nerves comes from traumatic nerve injuries rather than metabolic neuropathies like diabetic neuropathy, and high-quality randomized trials are still limited. It is not yet a standard treatment for neuropathy, but it is one of the more scientifically grounded regenerative approaches currently being studied. If a clinic is offering PRP injections for neuropathy, ask about the specific evidence for your type of nerve damage and whether it is being done within a research protocol.
Photobiomodulation and Low-Level Light Therapy
Low-level light therapy, also called photobiomodulation, uses red or near-infrared light to stimulate cellular repair processes. The light is absorbed by an enzyme in mitochondria, which increases energy production in the cell and modulates inflammation.31PubMed Central. Low level light therapy/photobiomodulation for diabetic peripheral neuropathy: protocol of a systematic review and meta-analysis Clinics and home devices marketed for neuropathy use this principle, and some patients report improved sensation and reduced pain.
The honest assessment of the evidence, however, is that it remains preliminary. Studies tend to be small, and the treatment protocols vary widely in wavelength, intensity, and duration. It is not harmful and has essentially no side effects, which makes it a reasonable addition for people who want to try everything available. But expecting dramatic results based on current evidence would be getting ahead of the science. If you are spending significant money on light therapy devices, keep your expectations calibrated accordingly.